[Clinical and electrophysiological study of isaxonine in peripheral facial paralysis (author's transl)].
In a double-blind survey carried out versus a placebo, the action of isaxonine was examined with 42 patients suffering from peripheral facial paralysis, most often a frigore. The statistical analysis of the clinical and electrophysiological results shows a significantly higher improvement for the isaxonine group, both in quality and speed of recovery of the nervus facialis functions. Clinical and biological tolerance posed no particular problem.
D004311:Double-Blind Method; D004341:Drug Evaluation; D004576:Electromyography; D004594:Electrophysiology; D005158:Facial Paralysis / Q000188:drug therapy*; D006801:Humans; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*
D011743:Pyrimidines; C020375:isaxonine
Etude clinique et électrophysiologique de l'isaxonine dans les paralysies faciales périphériques.